A tale of two viruses: The distinct spike glycoproteins of feline coronaviruses

Viruses

Volumn 12, Issue 1, 2020, Pages

  Jaimes, Javier A ^a   Millet, Jean K ^b   Stout, Alison E ^a   André, Nicole M ^a   Whittaker, Gary R ^a  

^a Cornell University ^*  (United States)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Feline coronavirus; Feline infectious peritonitis; Genetic characterization; Serotype; Spike protein

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CORONAVIRUS SPIKE GLYCOPROTEIN; DIPEPTIDYL PEPTIDASE IV; MICROSOMAL AMINOPEPTIDASE; POLYPROTEIN; VIRUS FUSION PROTEIN; VITRONECTIN; VIRUS RECEPTOR;

ALPHACORONAVIRUS; ALPHACORONAVIRUS 1; AMINO ACID SEQUENCE; BETACORONAVIRUS; BIOTYPE; CAT; ELECTRON TOMOGRAPHY; FELINE CORONAVIRUS; FELINE INFECTIOUS PERITONITIS; GAMMACORONAVIRUS; GENE DELETION; GENE MUTATION; GENETIC RECOMBINATION; GENOME ANALYSIS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; OPEN READING FRAME; PHYLOGENY; PORCINE RESPIRATORY CORONAVIRUS; RECEPTOR BINDING; REVIEW; SARS CORONAVIRUS; SEROTYPE; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; CHEMISTRY; GENETICS; MEMBRANE FUSION; METABOLISM; MOLECULAR MODEL; PATHOGENICITY; SPECIES DIFFERENCE; VIROLOGY;

ANIMALS; CATS; CORONAVIRUS, FELINE; FELINE INFECTIOUS PERITONITIS; MEMBRANE FUSION; MODELS, MOLECULAR; RECEPTORS, VIRUS; SEROGROUP; SPECIES SPECIFICITY; SPIKE GLYCOPROTEIN, CORONAVIRUS;

EID: 85077896560     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v12010083     Document Type: Review

References (80)

1. Masters, P.S.; Perlman, S. Coronaviridae. In Fields Virology, 6th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincot Williams & Wilkins: Philadelphia, PA, USA, 2013; Vol. 1, pp. 825–858.
2. Millet, J.K.; Whittaker, G.R. Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res. 2015, 202, 120–134. [CrossRef] [PubMed]
3. Song, Z.; Xu, Y.; Bao, L.; Zhang, L.; Yu, P.; Qu, Y.; Zhu, H.; Zhao, W.; Han, Y.; Qin, C. From SARS to MERS, Thrusting Coronaviruses into the Spotlight. Viruses 2019, 11, 59. [CrossRef]
4. Zumla, A.; Alagaili, A.N.; Cotten, M.; Azhar, E.I. Infectious diseases epidemic threats and mass gatherings: Refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV). BMC Med. 2016, 14, 132. [CrossRef] [PubMed]
5. Whittaker, G.R. Coronaviridae. In Fenner’s Veterinary Virology, 5th ed.; MacLachlan, N.J., Dubovi, E.J., Eds.; Academic Press: London, UK, 2017; pp. 435–462.
6. Kipar, A.; Meli, M.L. Feline infectious peritonitis: Still an enigma? Vet. Pathol. 2014, 51, 505–526. [CrossRef] [PubMed]
7. Wolfe, L.G.; Griesemer, R.A. Feline infectious peritonitis. Pathol. Vet. 1966, 3, 255–270. [CrossRef]
8. Pedersen, N.C. A review of feline infectious peritonitis virus infection: 1963–2008. J. Feline Med. Surg. 2009, 11, 225–258. [CrossRef]
9. Pedersen, N.C. An update on feline infectious peritonitis: Virology and immunopathogenesis. Vet. J. 2014, 201, 123–132. [CrossRef]
10. André, N.M.; Cossic, B.; Davies, E.; Miller, A.D.; Whittaker, G.R. Distinct mutation in the feline coronavirus spike protein cleavage activation site in a cat with feline infectious peritonitis-associated meningoencephalomyelitis. J. Feline Med. Surg. Open Rep. 2019, 5. [CrossRef]
11. Chang, H.W.; Egberink, H.F.; Halpin, R.; Spiro, D.J.; Rottier, P.J. Spike protein fusion peptide and feline coronavirus virulence. Emerg. Infect. Dis. 2012, 18, 1089–1095. [CrossRef]
12. Licitra, B.N.; Millet, J.K.; Regan, A.D.; Hamilton, B.S.; Rinaldi, V.D.; Duhamel, G.E.; Whittaker, G.R. Mutation in spike protein cleavage site and pathogenesis of feline coronavirus. Emerg. Infect. Dis. 2013, 19, 1066–1073. [CrossRef]
13. Porter, E.; Tasker, S.; Day, M.J.; Harley, R.; Kipar, A.; Siddell, S.G.; Helps, C.R. Amino acid changes in the spike protein of feline coronavirus correlate with systemic spread of virus from the intestine and not with feline infectious peritonitis. Vet. Res. 2014, 45, 49. [CrossRef] [PubMed]
14. Chang, H.W.; de Groot, R.J.; Egberink, H.F.; Rottier, P.J. Feline infectious peritonitis: Insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J. Gen. Virol. 2010, 91, 415–420. [CrossRef] [PubMed]
15. Perera, K.D.; Rathnayake, A.D.; Liu, H.; Pedersen, N.C.; Groutas, W.C.; Chang, K.O.; Kim, Y. Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor. Vet. Microbiol. 2019, 237, 108398. [CrossRef] [PubMed]
16. Murphy, B.G.; Perron, M.; Murakami, E.; Bauer, K.; Park, Y.; Eckstrand, C.; Liepnieks, M.; Pedersen, N.C. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet. Microbiol. 2018, 219, 226–233. [CrossRef] [PubMed]
17. Kim, Y.; Liu, H.; Galasiti Kankanamalage, A.C.; Weerasekara, S.; Hua, D.H.; Groutas, W.C.; Chang, K.-O.; Pedersen, N.C. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor. PLoS Pathog. 2016, 12, e1005531. [CrossRef]
18. Pedersen, N.C.; Perron, M.; Bannasch, M.; Montgomery, E.; Murakami, E.; Liepnieks, M.; Liu, H. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J. Feline Med. Surg. 2019, 21, 271–281. [CrossRef]
19. Pedersen, N.C.; Ward, J.; Mengeling, W.L. Antigenic relationship of the feline infectious peritonitis virus to coronaviruses of other species. Arch. Virol. 1978, 58, 45–53. [CrossRef]
20. Corapi, W.V.; Olsen, C.W.; Scott, F.W. Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J. Virol. 1992, 66, 6695–6705. [CrossRef]
21. Hohdatsu, T.; Okada, S.; Koyama, H. Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch. Virol. 1991, 117, 85–95. [CrossRef]
22. Pedersen, N.C.; Black, J.W.; Boyle, J.F.; Evermann, J.F.; McKeirnan, A.J.; Ott, R.L. Pathogenic differences between various feline coronavirus isolates. Adv. Exp. Med. Biol. 1984, 173, 365–380.
23. Addie, D.D.; Schaap, I.A.; Nicolson, L.; Jarrett, O. Persistence and transmission of natural type I feline coronavirus infection. J. Gen. Virol. 2003, 84, 2735–2744. [CrossRef] [PubMed]
24. Kummrow, M.; Meli, M.L.; Haessig, M.; Goenczi, E.; Poland, A.; Pedersen, N.C.; Hofmann-Lehmann, R.; Lutz, H. Feline coronavirus serotypes 1 and 2: Seroprevalence and association with disease in Switzerland. Clin. Diagn. Lab. Immunol. 2005, 12, 1209–1215. [CrossRef] [PubMed]
25. Li, C.; Liu, Q.; Kong, F.; Guo, D.; Zhai, J.; Su, M.; Sun, D. Circulation and genetic diversity of Feline coronavirus type I and II from clinically healthy and FIP-suspected cats in China. Transbound Emerg. Dis. 2019, 66, 763–775. [CrossRef] [PubMed]
26. Benetka, V.; Kubber-Heiss, A.; Kolodziejek, J.; Nowotny, N.; Hofmann-Parisot, M.; Mostl, K. Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet. Microbiol. 2004, 99, 31–42. [CrossRef]
27. Tekes, G.; Hofmann-Lehmann, R.; Bank-Wolf, B.; Maier, R.; Thiel, H.J.; Thiel, V. Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J. Virol. 2010, 84, 1326–1333. [CrossRef]
28. Herrewegh, A.A.P.M.; Smeenk, I.; Horzinek, M.C.; Rottier, P.J.M.; de Groot, R.J. Feline Coronavirus Type II Strains 79-1683 and 79-1146 Originate from a Double Recombination between Feline Coronavirus Type I and Canine Coronavirus. J. Virol. 1998, 72, 4508–4514. [CrossRef]
29. Whittaker, G.R.; Andre, N.M.; Millet, J.K. Improving Virus Taxonomy by Recontextualizing Sequence-Based Classification with Biologically Relevant Data: The Case of the Alphacoronavirus 1 Species. mSphere 2018, 3, e00463-17. [CrossRef]
30. Takano, T.; Endoh, M.; Fukatsu, H.; Sakurada, H.; Doki, T.; Hohdatsu, T. The cholesterol transport inhibitor U18666A inhibits type I feline coronavirus infection. Antivir. Res. 2017, 145, 96–102. [CrossRef]
31. Doki, T.; Yabe, M.; Takano, T.; Hohdatsu, T. Differential induction of type I interferon by type I and type II feline coronaviruses in vitro. Res. Vet. Sci. 2018, 120, 57–62. [CrossRef]
32. Olsen, C.W. A review of feline infectious peritonitis virus: Molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet. Microbiol. 1993, 36, 1–37. [CrossRef]
33. Dye, C.; Siddell, S.G. Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J. Gen. Virol. 2005, 86, 2249–2253. [CrossRef] [PubMed]
34. Nieto-Torres, J.L.; DeDiego, M.L.; Verdia-Baguena, C.; Jimenez-Guardeno, J.M.; Regla-Nava, J.A.; Fernandez-Delgado, R.; Castano-Rodriguez, C.; Alcaraz, A.; Torres, J.; Aguilella, V.M.; et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014, 10, e1004077. [CrossRef] [PubMed]
35. Jaimes, J.A.; Whittaker, G.R. Feline coronavirus: Insights into viral pathogenesis based on the spike protein structure and function. Virology 2018, 517, 108–121. [CrossRef] [PubMed]
36. Bosch, B.J.; van der Zee, R.; de Haan, C.A.M.; Rottier, P.J.M. The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex. J. Virol. 2003, 77, 8801–8811. [CrossRef]
37. White, J.M.; Delos, S.E.; Brecher, M.; Schornberg, K. Structures and mechanisms of viral membrane fusion proteins: Multiple variations on a common theme. Crit. Rev. Biochem. Mol. Biol. 2008, 43, 189–219. [CrossRef]
38. Chang, H.W.; Egberink, H.F.; Rottier, P.J. Sequence analysis of feline coronaviruses and the circulating virulent/avirulent theory. Emerg. Infect. Dis. 2011, 17, 744–746. [CrossRef]
39. Goodson, T.; Randell, S.; Moore, L. Feline infectious peritonitis. Compend. (YardleyPa) 2009, 31, E1–E8.
40. Pedersen, N.C.; Boyle, J.F.; Floyd, K.; Fudge, A.; Barker, J. An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am. J. Vet. Res. 1981, 42, 368–377.
41. Addie, D.D.; Toth, S.; Murray, G.D.; Jarrett, O. Risk of feline infectious peritonitis in cats naturally infected with feline coronavirus. Am. J. Vet. Res. 1995, 56, 429–434.
42. Tasker, S. Diagnosis of feline infectious peritonitis: Update on evidence supporting available tests. J. Feline Med. Surg. 2018, 20, 228–243. [CrossRef]
43. Doherty, M.J. Ocular manifestations of feline infectious peritonitis. J. Am. Vet. Med. Assoc. 1971, 159, 417–424. [PubMed]
44. Addie, D. Feline Coronavirus Infections. In Infectous Diseases of the Dog and Cat, 4th ed.; Greene, C.E., Ed.; Elsevier: St. Louis, MO, USA, 2012; pp. 102–108.
45. Decaro, N.; Martella, V.; Elia, G.; Campolo, M.; Desario, C.; Cirone, F.; Tempesta, M.; Buonavoglia, C. Molecular characterisation of the virulent canine coronavirus CB/05 strain. Virus Res. 2007, 125, 54–60. [CrossRef] [PubMed]
46. O’Brien, A.; Mettelman, R.C.; Volk, A.; Andre, N.M.; Whittaker, G.R.; Baker, S.C. Characterizing replication kinetics and plaque production of type I feline infectious peritonitis virus in three feline cell lines. Virology 2018, 525, 1–9. [CrossRef] [PubMed]
47. McKeirnan, A.J.; Evermann, J.F.; Davis, E.V.; Ott, R.L. Comparative properties of feline coronaviruses in vitro. Rev. Can. De Rech. Vet. 1987, 51, 212–216.
48. Terada, Y.; Matsui, N.; Noguchi, K.; Kuwata, R.; Shimoda, H.; Soma, T.; Mochizuki, M.; Maeda, K. Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses. PLoS ONE 2014, 9, e106534. [CrossRef]
49. Wang, Y.T.; Su, B.L.; Hsieh, L.E.; Chueh, L.L. An outbreak of feline infectious peritonitis in a Taiwanese shelter: Epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus. Vet. Res. 2013, 44, 57. [CrossRef]
50. Jaimes, J.A.; Millet, J.K.; Goldstein, M.E.; Whittaker, G.R.; Straus, M.R. A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation. J. Vis. Exp. 2019. [CrossRef]
51. de Haan, C.A.; Haijema, B.J.; Schellen, P.; Wichgers Schreur, P.; te Lintelo, E.; Vennema, H.; Rottier, P.J. Cleavage of group 1 coronavirus spike proteins: How furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation. J. Virol. 2008, 82, 6078–6083. [CrossRef]
52. Rasschaert, D.; Duarte, M.; Laude, H. Porcine respiratory coronavirus differs from transmissible gastroenteritis virus by a few genomic deletions. J. Gen. Virol. 1990, 71 (Pt. 11), 2599–2607. [CrossRef]
53. Pedersen, N.C.; Liu, H.; Dodd, K.A.; Pesavento, P.A. Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses 2009, 1, 166–184. [CrossRef]
54. Pedersen, N.C.; Liu, H.; Gandolfi, B.; Lyons, L.A. The influence of age and genetics on natural resistance to experimentally induced feline infectious peritonitis. Vet. Immunol. Immunopathol. 2014, 162, 33–40. [CrossRef] [PubMed]
55. McKeirnan, A.J.; Evermann, J.F.; Hargis, A.; Miller, L.M.; Ott, R.L. Isolation of feline coronaviruses from two cats with diverse disease manifestations. Feline Pract. 1981, 11, 16–20.
56. Li, F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu. Rev. Virol. 2016, 3, 237–261. [CrossRef] [PubMed]
57. Harrison, S.C. Principles of virus structure. In Fields Virology, 6th ed.; Knipe, D.M., Howley, P.M., Eds.; Lippincot Williams & Wilkins: Philadelphia, PA, USA, 2013; Vol. 1, pp. 52–86.
58. Floyd, D.L.; Ragains, J.R.; Skehel, J.J.; Harrison, S.C.; van Oijen, A.M. Single-particle kinetics of influenza virus membrane fusion. Proc. Natl. Acad. Sci. USA 2008, 105, 15382–15387. [CrossRef] [PubMed]
59. Belouzard, S.; Millet, J.K.; Licitra, B.N.; Whittaker, G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 2012, 4, 1011–1033. [CrossRef] [PubMed]
60. Madu, I.G.; Chu, V.C.; Lee, H.; Regan, A.D.; Bauman, B.E.; Whittaker, G.R. Heparan Sulfate Is a Selective Attachment Factor for the Avian Coronavirus Infectious Bronchitis Virus Beaudette. Avian Dis. 2007, 51, 45–51. [CrossRef]
61. Winter, C.; Schwegmann-Wessels, C.; Cavanagh, D.; Neumann, U.; Herrler, G. Sialic acid is a receptor determinant for infection of cells by avian Infectious bronchitis virus. J. Gen. Virol. 2006, 87, 1209–1216. [CrossRef]
62. Li, W.; Hulswit, R.J.G.; Widjaja, I.; Raj, V.S.; McBride, R.; Peng, W.; Widagdo, W.; Tortorici, M.A.; van Dieren, B.; Lang, Y.; et al. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. Proc. Natl. Acad. Sci. USA 2017, 114, E8508–E8517. [CrossRef]
63. Peng, G.; Sun, D.; Rajashankar, K.R.; Qian, Z.; Holmes, K.V.; Li, F. Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. Proc. Natl. Acad. Sci. USA 2011, 108, 10696–10701. [CrossRef]
64. Tresnan, D.B.; Levis, R.; Holmes, K.V. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J. Virol. 1996, 70, 8669–8674. [CrossRef]
65. Lu, G.; Hu, Y.; Wang, Q.; Qi, J.; Gao, F.; Li, Y.; Zhang, Y.; Zhang, W.; Yuan, Y.; Bao, J.; et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 2013, 500, 227–231. [CrossRef]
66. Lai, A.L.; Millet, J.K.; Daniel, S.; Freed, J.H.; Whittaker, G.R. The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner. J. Mol. Biol. 2017, 429, 3875–3892. [CrossRef] [PubMed]
67. White, J.M.; Whittaker, G.R. Fusion of Enveloped Viruses in Endosomes. Traffic 2016, 17, 593–614. [CrossRef] [PubMed]
68. Song, W.; Gui, M.; Wang, X.; Xiang, Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Pathog. 2018, 14, e1007236. [CrossRef] [PubMed]
69. Walls, A.C.; Xiong, X.; Park, Y.J.; Tortorici, M.A.; Snijder, J.; Quispe, J.; Cameroni, E.; Gopal, R.; Dai, M.; Lanzavecchia, A.; et al. Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion. Cell 2019, 176, 1026–1039.e15. [CrossRef]
70. Walls, A.C.; Tortorici, M.A.; Bosch, B.J.; Frenz, B.; Rottier, P.J.; DiMaio, F.; Rey, F.A.; Veesler, D. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature 2016, 531, 114–117. [CrossRef]
71. Walls, A.C.; Tortorici, M.A.; Frenz, B.; Snijder, J.; Li, W.; Rey, F.A.; DiMaio, F.; Bosch, B.J.; Veesler, D. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 2016, 23, 899–905. [CrossRef]
72. Shang, J.; Zheng, Y.; Yang, Y.; Liu, C.; Geng, Q.; Luo, C.; Zhang, W.; Li, F. Cryo-EM structure of infectious bronchitis coronavirus spike protein reveals structural and functional evolution of coronavirus spike proteins. PLoS Pathog. 2018, 14, e1007009. [CrossRef]
73. Shang, J.; Zheng, Y.; Yang, Y.; Liu, C.; Geng, Q.; Tai, W.; Du, L.; Zhou, Y.; Zhang, W.; Li, F. Cryo-EM structure of porcine delta coronavirus spike protein in the pre-fusion state. J. Virol. 2018, 14, e1007236. [CrossRef]
74. Hohdatsu, T.; Izumiya, Y.; Yokoyama, Y.; Kida, K.; Koyama, H. Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch. Virol. 1998, 143, 839–850. [CrossRef]
75. Regan, A.D.; Ousterout, D.G.; Whittaker, G.R. Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus. J. Virol. 2010, 84, 7917–7921. [CrossRef] [PubMed]
76. Regan, A.D.; Whittaker, G.R. Utilization of DC-SIGN for entry of feline coronaviruses into host cells. J. Virol. 2008, 82, 11992–11996. [CrossRef] [PubMed]
77. Look, A.T.; Ashmun, R.A.; Shapiro, L.H.; Peiper, S.C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Investig. 1989, 83, 1299–1307. [CrossRef] [PubMed]
78. Dye, C.; Temperton, N.; Siddell, S.G. Type I feline coronavirus spike glycoprotein fails to recognize aminopeptidase N as a functional receptor on feline cell lines. J. Gen. Virol. 2007, 88, 1753–1760. [CrossRef]
79. Regan, A.D.; Shraybman, R.; Cohen, R.D.; Whittaker, G.R. Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet. Microbiol. 2008, 132, 235–248. [CrossRef]
80. Licitra, B.N.; Sams, K.L.; Lee, D.W.; Whittaker, G.R. Feline Coronaviruses Associated with Feline Infectious Peritonitis Have Modifications to Spike Protein Activation Sites at Two Discrete Positions. Available online: https://arxiv.org/abs/1412.4034 (accessed on 10 December 2019).